Cargando…
A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration
The transport and accumulation of orally administered functional food-derived peptides in the brain was not fully explored. Thus, in the present study, we aimed to provide critical evidence regarding brain accumulation of a memory-improving soy dipeptide, Tyr-Pro, following oral administration. Stab...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560274/ https://www.ncbi.nlm.nih.gov/pubmed/37805661 http://dx.doi.org/10.1038/s41598-023-44161-z |
_version_ | 1785117696859308032 |
---|---|
author | Cheng, Lihong Tanaka, Mitsuru Yoshino, Atsuko Nagasato, Yuki Takata, Fuyuko Dohgu, Shinya Matsui, Toshiro |
author_facet | Cheng, Lihong Tanaka, Mitsuru Yoshino, Atsuko Nagasato, Yuki Takata, Fuyuko Dohgu, Shinya Matsui, Toshiro |
author_sort | Cheng, Lihong |
collection | PubMed |
description | The transport and accumulation of orally administered functional food-derived peptides in the brain was not fully explored. Thus, in the present study, we aimed to provide critical evidence regarding brain accumulation of a memory-improving soy dipeptide, Tyr-Pro, following oral administration. Stable isotope-labeled Tyr-Pro (Tyr-[(13)C(5),(15)N]Pro) was orally administered to male ICR mice at 10 or 100 mg/kg. Surprisingly, the intact labeled Tyr-Pro exhibited maximal plasma and brain levels 15 min after administration (plasma: area under the curve [AUC(0–120 min)], 1331 ± 267 pmol·min/mL-plasma; brain: AUC(0–120 min) of 0.34 ± 0.11 pmol·min/mg-dry brain, at 10 mg/kg). In addition, we detected labeled Tyr-Pro in the brain parenchyma, indicating a validated blood–brain-barrier (BBB) transportability. Moreover, we confirmed the preferable accumulation of Tyr-Pro in the hypothalamus, hippocampus, and cortex with > 0.02 pmol/mg-tissue. In conclusion, we provided the first evidence that orally administered Tyr-Pro at 10 mg/kg directly entered the blood circulation with an absorption ratio of 0.15%, of which 2.5% of Tyr-Pro was transported from the plasma to the mouse brain parenchyma. |
format | Online Article Text |
id | pubmed-10560274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105602742023-10-09 A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration Cheng, Lihong Tanaka, Mitsuru Yoshino, Atsuko Nagasato, Yuki Takata, Fuyuko Dohgu, Shinya Matsui, Toshiro Sci Rep Article The transport and accumulation of orally administered functional food-derived peptides in the brain was not fully explored. Thus, in the present study, we aimed to provide critical evidence regarding brain accumulation of a memory-improving soy dipeptide, Tyr-Pro, following oral administration. Stable isotope-labeled Tyr-Pro (Tyr-[(13)C(5),(15)N]Pro) was orally administered to male ICR mice at 10 or 100 mg/kg. Surprisingly, the intact labeled Tyr-Pro exhibited maximal plasma and brain levels 15 min after administration (plasma: area under the curve [AUC(0–120 min)], 1331 ± 267 pmol·min/mL-plasma; brain: AUC(0–120 min) of 0.34 ± 0.11 pmol·min/mg-dry brain, at 10 mg/kg). In addition, we detected labeled Tyr-Pro in the brain parenchyma, indicating a validated blood–brain-barrier (BBB) transportability. Moreover, we confirmed the preferable accumulation of Tyr-Pro in the hypothalamus, hippocampus, and cortex with > 0.02 pmol/mg-tissue. In conclusion, we provided the first evidence that orally administered Tyr-Pro at 10 mg/kg directly entered the blood circulation with an absorption ratio of 0.15%, of which 2.5% of Tyr-Pro was transported from the plasma to the mouse brain parenchyma. Nature Publishing Group UK 2023-10-07 /pmc/articles/PMC10560274/ /pubmed/37805661 http://dx.doi.org/10.1038/s41598-023-44161-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Cheng, Lihong Tanaka, Mitsuru Yoshino, Atsuko Nagasato, Yuki Takata, Fuyuko Dohgu, Shinya Matsui, Toshiro A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title | A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title_full | A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title_fullStr | A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title_full_unstemmed | A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title_short | A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration |
title_sort | memory-improving dipeptide, tyr-pro, can reach the mouse brain after oral administration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560274/ https://www.ncbi.nlm.nih.gov/pubmed/37805661 http://dx.doi.org/10.1038/s41598-023-44161-z |
work_keys_str_mv | AT chenglihong amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT tanakamitsuru amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT yoshinoatsuko amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT nagasatoyuki amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT takatafuyuko amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT dohgushinya amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT matsuitoshiro amemoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT chenglihong memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT tanakamitsuru memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT yoshinoatsuko memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT nagasatoyuki memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT takatafuyuko memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT dohgushinya memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration AT matsuitoshiro memoryimprovingdipeptidetyrprocanreachthemousebrainafteroraladministration |